Bhatnagar Anish, CHIEF EXECUTIVE OFFICER at SOLENO THERAPEUTICS INC (SLNO), sold 230,008 shares at $47.83 ($10.9M) on 2024-08-29, disclosed to the SEC on 2024-08-30.
Open-market sale of $10.9M SLNO by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.19 | 30,262 | $1.4M | 13.1% |
| 2 | $47.19 | 30,262 | $1.4M | 13.1% |
| 3 | $48.03 | 26,351 | $1.3M | 11.6% |
| 4 | $48.03 | 26,351 | $1.3M | 11.6% |
| 5 | $47.16 | 47,551 | $2.2M | 20.6% |
| 6 | $47.16 | 47,551 |
| $2.2M |
| 20.6% |
| 7 | $47.83 | 10,840 | $518K | 4.8% |
| 8 | $47.83 | 10,840 | $518K | 4.8% |
| Total | $47.43 avg | 230,008 | $10.9M | 100% |
| Filing → |
| SLNO | SELL | 2024-10-03 | $2.0M | — | Filing → |
| SLNO | SELL | 2024-08-07 | $11.6M | — | Filing → |
| SLNO | SELL | 2024-07-03 | $1.6M | — | Filing → |